| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | superoxide-generating NADPH oxidase activator activity | 8.19e-07 | 10 | 39 | 3 | GO:0016176 | |
| GeneOntologyMolecularFunction | superoxide-generating NAD(P)H oxidase activity | 1.50e-06 | 12 | 39 | 3 | GO:0016175 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor | 7.67e-06 | 20 | 39 | 3 | GO:0050664 | |
| GeneOntologyMolecularFunction | phosphatidylinositol-3,4-bisphosphate binding | 4.32e-05 | 35 | 39 | 3 | GO:0043325 | |
| GeneOntologyMolecularFunction | molecular function activator activity | 4.97e-04 | 1233 | 39 | 9 | GO:0140677 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated channel activity | 6.91e-04 | 20 | 39 | 2 | GO:0141147 | |
| GeneOntologyMolecularFunction | intracellularly calcium-gated chloride channel activity | 6.91e-04 | 20 | 39 | 2 | GO:0005229 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on NAD(P)H | 8.42e-04 | 95 | 39 | 3 | GO:0016651 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 9.16e-04 | 23 | 39 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | enzyme activator activity | 1.59e-03 | 656 | 39 | 6 | GO:0008047 | |
| GeneOntologyMolecularFunction | fibronectin binding | 2.50e-03 | 38 | 39 | 2 | GO:0001968 | |
| GeneOntologyMolecularFunction | SH3 domain binding | 2.72e-03 | 143 | 39 | 3 | GO:0017124 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of gram-positive bacterium | 4.89e-11 | 5 | 38 | 4 | GO:0070946 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of bacterium | 6.95e-11 | 16 | 38 | 5 | GO:0070944 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of symbiont cell | 1.84e-10 | 19 | 38 | 5 | GO:0070943 | |
| GeneOntologyBiologicalProcess | neutrophil mediated cytotoxicity | 3.22e-10 | 21 | 38 | 5 | GO:0070942 | |
| GeneOntologyBiologicalProcess | killing by host of symbiont cells | 7.75e-09 | 38 | 38 | 5 | GO:0051873 | |
| GeneOntologyBiologicalProcess | neutrophil mediated immunity | 2.61e-08 | 48 | 38 | 5 | GO:0002446 | |
| GeneOntologyBiologicalProcess | neutrophil-mediated killing of fungus | 2.01e-07 | 7 | 38 | 3 | GO:0070947 | |
| GeneOntologyBiologicalProcess | NADP catabolic process | 2.01e-07 | 7 | 38 | 3 | GO:0006742 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst involved in inflammatory response | 9.42e-07 | 11 | 38 | 3 | GO:0060264 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in inflammatory response | 1.63e-06 | 13 | 38 | 3 | GO:0002536 | |
| GeneOntologyBiologicalProcess | NADP metabolic process | 3.36e-06 | 56 | 38 | 4 | GO:0006739 | |
| GeneOntologyBiologicalProcess | disruption of cell in another organism | 3.77e-06 | 129 | 38 | 5 | GO:0141061 | |
| GeneOntologyBiologicalProcess | killing of cells of another organism | 3.77e-06 | 129 | 38 | 5 | GO:0031640 | |
| GeneOntologyBiologicalProcess | disruption of anatomical structure in another organism | 4.21e-06 | 132 | 38 | 5 | GO:0141060 | |
| GeneOntologyBiologicalProcess | response to yeast | 4.62e-06 | 18 | 38 | 3 | GO:0001878 | |
| GeneOntologyBiologicalProcess | biological process involved in interaction with symbiont | 4.71e-06 | 135 | 38 | 5 | GO:0051702 | |
| GeneOntologyBiologicalProcess | respiratory burst involved in defense response | 6.44e-06 | 20 | 38 | 3 | GO:0002679 | |
| GeneOntologyBiologicalProcess | myeloid leukocyte mediated immunity | 7.37e-06 | 148 | 38 | 5 | GO:0002444 | |
| GeneOntologyBiologicalProcess | negative regulation of smooth muscle contraction | 8.67e-06 | 22 | 38 | 3 | GO:0045986 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide biosynthetic process | 8.67e-06 | 22 | 38 | 3 | GO:0050665 | |
| GeneOntologyBiologicalProcess | defense response to fungus | 8.71e-06 | 71 | 38 | 4 | GO:0050832 | |
| GeneOntologyBiologicalProcess | regulation of respiratory burst | 9.96e-06 | 23 | 38 | 3 | GO:0060263 | |
| GeneOntologyBiologicalProcess | response to fungus | 1.78e-05 | 85 | 38 | 4 | GO:0009620 | |
| GeneOntologyBiologicalProcess | leukocyte mediated cytotoxicity | 2.29e-05 | 187 | 38 | 5 | GO:0001909 | |
| GeneOntologyBiologicalProcess | negative regulation of muscle contraction | 3.63e-05 | 35 | 38 | 3 | GO:0045932 | |
| GeneOntologyBiologicalProcess | leukotriene metabolic process | 5.86e-05 | 41 | 38 | 3 | GO:0006691 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide catabolic process | 6.68e-05 | 119 | 38 | 4 | GO:0019364 | |
| GeneOntologyBiologicalProcess | respiratory burst | 6.77e-05 | 43 | 38 | 3 | GO:0045730 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound catabolic process | 7.60e-05 | 123 | 38 | 4 | GO:0072526 | |
| GeneOntologyBiologicalProcess | production of molecular mediator involved in inflammatory response | 1.03e-04 | 133 | 38 | 4 | GO:0002532 | |
| GeneOntologyBiologicalProcess | superoxide anion generation | 1.07e-04 | 50 | 38 | 3 | GO:0042554 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 1.64e-04 | 150 | 38 | 4 | GO:0050830 | |
| GeneOntologyBiologicalProcess | cellular defense response | 1.84e-04 | 60 | 38 | 3 | GO:0006968 | |
| GeneOntologyBiologicalProcess | cell killing | 2.37e-04 | 307 | 38 | 5 | GO:0001906 | |
| GeneOntologyBiologicalProcess | hydrogen peroxide metabolic process | 2.55e-04 | 67 | 38 | 3 | GO:0042743 | |
| GeneOntologyBiologicalProcess | purine nucleotide catabolic process | 3.42e-04 | 182 | 38 | 4 | GO:0006195 | |
| GeneOntologyBiologicalProcess | purine-containing compound catabolic process | 3.87e-04 | 188 | 38 | 4 | GO:0072523 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle contraction | 4.14e-04 | 79 | 38 | 3 | GO:0006940 | |
| GeneOntologyBiologicalProcess | reactive oxygen species biosynthetic process | 4.30e-04 | 80 | 38 | 3 | GO:1903409 | |
| GeneOntologyBiologicalProcess | biological process involved in symbiotic interaction | 4.39e-04 | 351 | 38 | 5 | GO:0044403 | |
| GeneOntologyBiologicalProcess | superoxide metabolic process | 4.79e-04 | 83 | 38 | 3 | GO:0006801 | |
| GeneOntologyBiologicalProcess | nicotinamide nucleotide metabolic process | 5.08e-04 | 202 | 38 | 4 | GO:0046496 | |
| GeneOntologyBiologicalProcess | pyridine nucleotide metabolic process | 5.08e-04 | 202 | 38 | 4 | GO:0019362 | |
| GeneOntologyBiologicalProcess | nucleotide catabolic process | 5.67e-04 | 208 | 38 | 4 | GO:0009166 | |
| GeneOntologyBiologicalProcess | pyridine-containing compound metabolic process | 5.88e-04 | 210 | 38 | 4 | GO:0072524 | |
| GeneOntologyBiologicalProcess | nucleoside phosphate catabolic process | 6.53e-04 | 216 | 38 | 4 | GO:1901292 | |
| GeneOntologyBiologicalProcess | defense response to bacterium | 8.38e-04 | 405 | 38 | 5 | GO:0042742 | |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 1.00e-03 | 107 | 38 | 3 | GO:0051492 | |
| GeneOntologyBiologicalProcess | regulation of insulin-like growth factor receptor signaling pathway | 1.30e-03 | 29 | 38 | 2 | GO:0043567 | |
| GeneOntologyBiologicalProcess | negative regulation of protein localization | 1.36e-03 | 263 | 38 | 4 | GO:1903828 | |
| GeneOntologyBiologicalProcess | regulation of actomyosin structure organization | 1.46e-03 | 122 | 38 | 3 | GO:0110020 | |
| GeneOntologyBiologicalProcess | regulation of actin filament bundle assembly | 1.50e-03 | 123 | 38 | 3 | GO:0032231 | |
| GeneOntologyBiologicalProcess | contractile actin filament bundle assembly | 1.64e-03 | 127 | 38 | 3 | GO:0030038 | |
| GeneOntologyBiologicalProcess | stress fiber assembly | 1.64e-03 | 127 | 38 | 3 | GO:0043149 | |
| GeneOntologyBiologicalProcess | organophosphate catabolic process | 1.73e-03 | 281 | 38 | 4 | GO:0046434 | |
| GeneOntologyBiologicalProcess | smooth muscle contraction | 1.87e-03 | 133 | 38 | 3 | GO:0006939 | |
| GeneOntologyBiologicalProcess | reactive oxygen species metabolic process | 1.96e-03 | 291 | 38 | 4 | GO:0072593 | |
| GeneOntologyBiologicalProcess | icosanoid metabolic process | 2.26e-03 | 142 | 38 | 3 | GO:0006690 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine kinase signaling pathway | 2.27e-03 | 747 | 38 | 6 | GO:0007169 | |
| GeneOntologyBiologicalProcess | negative regulation of protein transport | 2.79e-03 | 153 | 38 | 3 | GO:0051224 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | 2.82e-03 | 780 | 38 | 6 | GO:0042327 | |
| GeneOntologyCellularComponent | NADPH oxidase complex | 4.81e-06 | 18 | 39 | 3 | GO:0043020 | |
| GeneOntologyCellularComponent | bicellular tight junction | 1.02e-04 | 131 | 39 | 4 | GO:0005923 | |
| GeneOntologyCellularComponent | tight junction | 1.29e-04 | 139 | 39 | 4 | GO:0070160 | |
| GeneOntologyCellularComponent | apical junction complex | 2.10e-04 | 158 | 39 | 4 | GO:0043296 | |
| MousePheno | increased angiotensin I-converting enzyme activity | 2.62e-07 | 6 | 34 | 3 | MP:0003184 | |
| MousePheno | abnormal angiotensin I-converting enzyme activity | 2.62e-07 | 6 | 34 | 3 | MP:0013254 | |
| MousePheno | liver abscess | 4.57e-07 | 7 | 34 | 3 | MP:0003332 | |
| MousePheno | impaired granulocyte bactericidal activity | 1.56e-06 | 10 | 34 | 3 | MP:0005074 | |
| MousePheno | decreased susceptibility to Orthomyxoviridae infection | 1.05e-05 | 18 | 34 | 3 | MP:0020947 | |
| MousePheno | decreased vasoconstriction | 1.96e-05 | 22 | 34 | 3 | MP:0003026 | |
| MousePheno | reduced long-term potentiation | 2.14e-05 | 141 | 34 | 5 | MP:0001473 | |
| MousePheno | increased circulating renin level | 2.25e-05 | 23 | 34 | 3 | MP:0003352 | |
| MousePheno | abnormal circulating renin level | 4.60e-05 | 29 | 34 | 3 | MP:0003349 | |
| MousePheno | skin lesions | 6.71e-05 | 91 | 34 | 4 | MP:0001212 | |
| MousePheno | impaired smooth muscle contractility | 8.16e-05 | 35 | 34 | 3 | MP:0000740 | |
| MousePheno | granulomatous inflammation | 8.89e-05 | 36 | 34 | 3 | MP:0002500 | |
| MousePheno | pale yolk sac | 1.40e-04 | 110 | 34 | 4 | MP:0001722 | |
| MousePheno | abnormal long-term potentiation | 1.81e-04 | 221 | 34 | 5 | MP:0002207 | |
| MousePheno | increased heart atrium size | 1.86e-04 | 46 | 34 | 3 | MP:0008725 | |
| MousePheno | abnormal vascular endothelial cell physiology | 1.98e-04 | 47 | 34 | 3 | MP:0004003 | |
| MousePheno | abnormal vasoconstriction | 2.38e-04 | 50 | 34 | 3 | MP:0000250 | |
| MousePheno | abnormal susceptibility to Orthomyxoviridae infection | 3.00e-04 | 54 | 34 | 3 | MP:0020945 | |
| MousePheno | abnormal heart atrium size | 3.00e-04 | 54 | 34 | 3 | MP:0031576 | |
| MousePheno | single kidney | 4.30e-04 | 61 | 34 | 3 | MP:0003604 | |
| MousePheno | oxidative stress | 4.83e-04 | 152 | 34 | 4 | MP:0003674 | |
| MousePheno | abnormal bile duct morphology | 4.95e-04 | 64 | 34 | 3 | MP:0002928 | |
| MousePheno | abnormal spatial learning | 5.04e-04 | 276 | 34 | 5 | MP:0001463 | |
| MousePheno | abnormal intestinal goblet cell morphology | 5.42e-04 | 66 | 34 | 3 | MP:0003449 | |
| MousePheno | abnormal intestinal mucosa morphology | 6.15e-04 | 162 | 34 | 4 | MP:0000511 | |
| MousePheno | enhanced long-term potentiation | 6.17e-04 | 69 | 34 | 3 | MP:0003008 | |
| MousePheno | abnormal vascular wound healing | 7.28e-04 | 73 | 34 | 3 | MP:0004883 | |
| MousePheno | abnormal redox activity | 7.86e-04 | 173 | 34 | 4 | MP:0003186 | |
| MousePheno | chronic inflammation | 9.16e-04 | 79 | 34 | 3 | MP:0002499 | |
| MousePheno | decreased susceptibility to Riboviria infection | 1.02e-03 | 82 | 34 | 3 | MP:0020914 | |
| MousePheno | impaired cued conditioning behavior | 1.02e-03 | 82 | 34 | 3 | MP:0009456 | |
| MousePheno | abnormal wound healing | 1.18e-03 | 193 | 34 | 4 | MP:0005023 | |
| MousePheno | abnormal response to cardiac infarction | 1.52e-03 | 94 | 34 | 3 | MP:0000343 | |
| MousePheno | abnormal vascular development | 1.76e-03 | 542 | 34 | 6 | MP:0000259 | |
| MousePheno | dilated heart | 1.79e-03 | 216 | 34 | 4 | MP:0004937 | |
| MousePheno | abnormal intestine morphology | 1.83e-03 | 546 | 34 | 6 | MP:0000477 | |
| MousePheno | abnormal angiogenesis | 1.91e-03 | 372 | 34 | 5 | MP:0000260 | |
| MousePheno | dilated heart left ventricle | 2.25e-03 | 108 | 34 | 3 | MP:0002753 | |
| MousePheno | abnormal heart atrium morphology | 2.32e-03 | 232 | 34 | 4 | MP:0003105 | |
| MousePheno | pericardial effusion | 2.44e-03 | 111 | 34 | 3 | MP:0005312 | |
| MousePheno | abnormal visceral yolk sac morphology | 2.47e-03 | 236 | 34 | 4 | MP:0001718 | |
| MousePheno | abnormal locomotor activation | 2.50e-03 | 112 | 34 | 3 | MP:0003313 | |
| MousePheno | abnormal biliary tract morphology | 2.83e-03 | 117 | 34 | 3 | MP:0005083 | |
| Domain | Anoctamin | 1.70e-04 | 10 | 37 | 2 | PF04547 | |
| Domain | Anoctamin | 1.70e-04 | 10 | 37 | 2 | IPR007632 | |
| Domain | CarboxyPept-like_regulatory | 5.10e-04 | 17 | 37 | 2 | IPR008969 | |
| Domain | PDZ | 2.71e-03 | 141 | 37 | 3 | PF00595 | |
| Domain | PDZ | 3.11e-03 | 148 | 37 | 3 | SM00228 | |
| Domain | - | 3.23e-03 | 150 | 37 | 3 | 2.30.42.10 | |
| Domain | PDZ | 3.29e-03 | 151 | 37 | 3 | PS50106 | |
| Domain | PDZ | 3.35e-03 | 152 | 37 | 3 | IPR001478 | |
| Domain | - | 7.24e-03 | 391 | 37 | 4 | 2.30.29.30 | |
| Domain | - | 9.19e-03 | 73 | 37 | 2 | 2.60.120.260 | |
| Domain | PH_dom-like | 9.73e-03 | 426 | 37 | 4 | IPR011993 | |
| Domain | TyrKc | 1.31e-02 | 88 | 37 | 2 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 1.31e-02 | 88 | 37 | 2 | IPR020635 | |
| Domain | SAM | 1.31e-02 | 88 | 37 | 2 | SM00454 | |
| Domain | TRYPSIN_SER | 1.37e-02 | 90 | 37 | 2 | IPR033116 | |
| Pathway | REACTOME_CROSS_PRESENTATION_OF_PARTICULATE_EXOGENOUS_ANTIGENS_PHAGOSOMES | 6.52e-07 | 9 | 29 | 3 | MM14524 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_NADPH_OXIDASES | 1.75e-05 | 25 | 29 | 3 | MM15269 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 2.86e-05 | 87 | 29 | 4 | MM15600 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 3.72e-05 | 93 | 29 | 4 | MM15609 | |
| Pathway | BIOCARTA_FMLP_PATHWAY | 4.49e-05 | 34 | 29 | 3 | MM1399 | |
| Pathway | REACTOME_DETOXIFICATION_OF_REACTIVE_OXYGEN_SPECIES | 4.90e-05 | 35 | 29 | 3 | MM14944 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 5.55e-05 | 103 | 29 | 4 | MM14752 | |
| Pathway | REACTOME_ROS_AND_RNS_PRODUCTION_IN_PHAGOCYTES | 6.29e-05 | 38 | 29 | 3 | MM14519 | |
| Pathway | WP_MICROGLIA_PATHOGEN_PHAGOCYTOSIS_PATHWAY | 1.12e-04 | 46 | 29 | 3 | MM15837 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_TRANSPORT_AND_UPTAKE_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | 1.14e-04 | 124 | 29 | 4 | M27285 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 1.74e-04 | 418 | 29 | 6 | MM15587 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 2.28e-04 | 439 | 29 | 6 | MM15595 | |
| Pathway | REACTOME_INDUCTION_OF_CELL_CELL_FUSION | 3.14e-04 | 13 | 29 | 2 | M46426 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 4.28e-04 | 175 | 29 | 4 | MM15599 | |
| Pathway | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | 4.97e-04 | 76 | 29 | 3 | MM14526 | |
| Pathway | WP_CHEMOKINE_SIGNALING_PATHWAY | 5.17e-04 | 184 | 29 | 4 | MM15943 | |
| Pathway | WP_OXIDATIVE_STRESS_AND_REDOX_PATHWAY | 8.69e-04 | 92 | 29 | 3 | MM15823 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.08e-03 | 99 | 29 | 3 | MM14910 | |
| Pathway | REACTOME_STIMULI_SENSING_CHANNELS | 1.31e-03 | 106 | 29 | 3 | M27200 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 1.78e-03 | 649 | 29 | 6 | MM15690 | |
| Pubmed | 6.74e-12 | 5 | 39 | 4 | 10714686 | ||
| Pubmed | Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense. | 2.02e-11 | 6 | 39 | 4 | 22163282 | |
| Pubmed | Killing activity of neutrophils is mediated through activation of proteases by K+ flux. | 4.71e-11 | 7 | 39 | 4 | 11907569 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 18036262 | ||
| Pubmed | Transient loss of resistance to pulmonary tuberculosis in p47(phox-/-) mice. | 1.30e-09 | 3 | 39 | 3 | 10678931 | |
| Pubmed | Colitis susceptibility in p47(phox-/-) mice is mediated by the microbiome. | 1.30e-09 | 3 | 39 | 3 | 27044504 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17167081 | ||
| Pubmed | Mice lacking NCF1 exhibit reduced growth of implanted melanoma and carcinoma tumors. | 1.30e-09 | 3 | 39 | 3 | 24358335 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 10891396 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 25474113 | ||
| Pubmed | NADPH oxidase in bone marrow-derived cells mediates pulmonary ischemia-reperfusion injury. | 1.30e-09 | 3 | 39 | 3 | 18787174 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26209274 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 24873968 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 22184329 | ||
| Pubmed | NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. | 1.30e-09 | 3 | 39 | 3 | 11018074 | |
| Pubmed | Natural Loss-of-Function Mutations in Qa2 and NCF1 Cause the Spread of Mannan-Induced Psoriasis. | 1.30e-09 | 3 | 39 | 3 | 33545139 | |
| Pubmed | Small-molecule screen identifies reactive oxygen species as key regulators of neutrophil chemotaxis. | 1.30e-09 | 3 | 39 | 3 | 20142487 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 9116268 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 20686129 | ||
| Pubmed | Angiotensin II induced catabolic effect and muscle atrophy are redox dependent. | 1.30e-09 | 3 | 39 | 3 | 21570954 | |
| Pubmed | p47(phox) contributes to albuminuria and kidney fibrosis in mice. | 1.30e-09 | 3 | 39 | 3 | 25565313 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 39357591 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 12958309 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 11435342 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 31118934 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 23482812 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 16041040 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 10085000 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 10987289 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 21435178 | ||
| Pubmed | Intermittent hypoxia has organ-specific effects on oxidative stress. | 1.30e-09 | 3 | 39 | 3 | 18703411 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 29228045 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17307863 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 22155727 | ||
| Pubmed | Ncf1 affects osteoclast formation but is not critical for postmenopausal bone loss. | 1.30e-09 | 3 | 39 | 3 | 27829407 | |
| Pubmed | Mechanism of endoplasmic reticulum stress-induced vascular endothelial dysfunction. | 1.30e-09 | 3 | 39 | 3 | 24576409 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 22376231 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 23918780 | ||
| Pubmed | NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells. | 1.30e-09 | 3 | 39 | 3 | 28274989 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26645958 | ||
| Pubmed | Role of p47(phox) in vascular oxidative stress and hypertension caused by angiotensin II. | 1.30e-09 | 3 | 39 | 3 | 12364355 | |
| Pubmed | NADPH oxidase promotes neutrophil extracellular trap formation in pulmonary aspergillosis. | 1.30e-09 | 3 | 39 | 3 | 24549323 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 34557202 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 28467721 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 10670582 | ||
| Pubmed | NADPH oxidase deficiency regulates Th lineage commitment and modulates autoimmunity. | 1.30e-09 | 3 | 39 | 3 | 20881184 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26528554 | ||
| Pubmed | The role of reactive oxygen species in immunopathogenesis of rheumatoid arthritis. | 1.30e-09 | 3 | 39 | 3 | 19052348 | |
| Pubmed | Effect of early particulate air pollution exposure on obesity in mice: role of p47phox. | 1.30e-09 | 3 | 39 | 3 | 20864666 | |
| Pubmed | Reactive oxygen species delay control of lymphocytic choriomeningitis virus. | 1.30e-09 | 3 | 39 | 3 | 23328631 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 34572995 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17114280 | ||
| Pubmed | Participation of mitochondrial respiratory complex III in neutrophil activation and lung injury. | 1.30e-09 | 3 | 39 | 3 | 19168575 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 25989352 | ||
| Pubmed | NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. | 1.30e-09 | 3 | 39 | 3 | 19503084 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17404617 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17332431 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 36592568 | ||
| Pubmed | Genetic requirement of p47phox for superoxide production by murine microglia. | 1.30e-09 | 3 | 39 | 3 | 11156938 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 30504842 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 10772875 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 27798190 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 20702812 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 33705493 | ||
| Pubmed | Inhibition of NADPH oxidase by apocynin attenuates progression of atherosclerosis. | 1.30e-09 | 3 | 39 | 3 | 23965970 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 26455429 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 15513930 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 15626477 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 15033459 | ||
| Pubmed | NCF1 gene and pseudogene pattern: association with parasitic infection and autoimmunity. | 1.30e-09 | 3 | 39 | 3 | 19077231 | |
| Pubmed | Neutrophil-derived ROS contribute to oxidative DNA damage induction by quartz particles. | 1.30e-09 | 3 | 39 | 3 | 20828610 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 20817944 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 22319452 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 16895801 | ||
| Pubmed | Role and cellular source of nicotinamide adenine dinucleotide phosphate oxidase in hepatic fibrosis. | 1.30e-09 | 3 | 39 | 3 | 20690191 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 16772302 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 32504071 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 16280459 | ||
| Pubmed | Defective tryptophan catabolism underlies inflammation in mouse chronic granulomatous disease. | 1.30e-09 | 3 | 39 | 3 | 18185592 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 36853827 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 23024271 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 21253614 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 25873172 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 15310853 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 31393787 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 10725280 | ||
| Pubmed | Ncf1 Governs Immune Niches in the Lung to Mediate Pulmonary Inflammation in Mice. | 1.30e-09 | 3 | 39 | 3 | 34970267 | |
| Pubmed | Germ-free mice deficient of reactive oxygen species have increased arthritis susceptibility. | 1.30e-09 | 3 | 39 | 3 | 25689796 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 14993144 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 22050439 | ||
| Pubmed | The vascular NADPH oxidase subunit p47phox is involved in redox-mediated gene expression. | 1.30e-09 | 3 | 39 | 3 | 12031896 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 11249873 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 15936744 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 17220182 | ||
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 25628043 | ||
| Pubmed | The p47phox mouse knock-out model of chronic granulomatous disease. | 1.30e-09 | 3 | 39 | 3 | 7650482 | |
| Pubmed | Disseminated trichosporonosis in a murine model of chronic granulomatous disease. | 1.30e-09 | 3 | 39 | 3 | 12868577 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 12560337 | ||
| Pubmed | NADPH oxidase mediates striatal neuronal injury after transient global cerebral ischemia. | 1.30e-09 | 3 | 39 | 3 | 20859296 | |
| Pubmed | 1.30e-09 | 3 | 39 | 3 | 35276443 | ||
| Cytoband | 8q22 | 7.33e-05 | 15 | 39 | 2 | 8q22 | |
| Cytoband | 7q11.23 | 7.91e-05 | 97 | 39 | 3 | 7q11.23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7q11 | 1.59e-03 | 271 | 39 | 3 | chr7q11 | |
| Cytoband | 16q22.1 | 3.98e-03 | 110 | 39 | 2 | 16q22.1 | |
| GeneFamily | Anoctamins | 8.20e-05 | 10 | 25 | 2 | 865 | |
| GeneFamily | PDZ domain containing | 1.17e-03 | 152 | 25 | 3 | 1220 | |
| GeneFamily | Sterile alpha motif domain containing | 6.53e-03 | 88 | 25 | 2 | 760 | |
| Coexpression | GAVIN_PDE3B_TARGETS | 6.85e-06 | 25 | 39 | 3 | MM726 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_D_DN | 1.16e-05 | 94 | 39 | 4 | MM787 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.23e-07 | 194 | 39 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 173 | 39 | 4 | 75e26a65071b0d2f30ed0b2aa9859c488f5cf362 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.56e-05 | 173 | 39 | 4 | 26e2e674f5d312fa8f61c11b553dc6101f063b16 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-05 | 179 | 39 | 4 | 124da6f882968dc0d05f3edd8f3b4d61617cc214 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Dendritic-plasmacytoid_dendritic_cell-DC_c4-LILRA4|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.79e-05 | 179 | 39 | 4 | edc5ef693dc4e7ea70717b77fb908fc784dce3a2 | |
| ToppCell | facs-Lung-24m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-05 | 184 | 39 | 4 | d754c3de621429b220ae4ac426cdfc619e848462 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.21e-05 | 189 | 39 | 4 | b0244a9d1b5c8ad4708750b691184f3491b13900 | |
| ToppCell | B_cell_maturation|World / Lineage and Cell class | 2.26e-05 | 190 | 39 | 4 | 301782283d0c604fb3b428a8ddf1f7cd8e63a90b | |
| ToppCell | BLOOD--(2)_Memory_B_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.35e-05 | 192 | 39 | 4 | 9c3a4699f05f1a757d6e37d9f15675e970584cca | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 193 | 39 | 4 | 325859399411d0e66a78a385dffa886df9af3198 | |
| ToppCell | 10x5'v1-week_14-16-Lymphocytic_B-B_lineage-naive_B_cell|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.45e-05 | 194 | 39 | 4 | 4a4cc61193344bb151439f63d0584abddde47cf0 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_B|bone_marrow / Manually curated celltypes from each tissue | 2.50e-05 | 195 | 39 | 4 | bcbf0305ca9337a6f3021178dbb47a7fbf1030a4 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.60e-05 | 197 | 39 | 4 | f7a8440d2b8b17d9726c6fe3dd383effbfebab13 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.60e-05 | 197 | 39 | 4 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | proximal-Hematologic-B_cell|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-05 | 197 | 39 | 4 | 735b5026d28cd3677947ae8e462f6fd640cf9c9b | |
| ToppCell | Bronchial-NucSeq-Immune_Lymphocytic-B|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.60e-05 | 197 | 39 | 4 | 0f489d26e4013d1b5a90559856ed2de32a0bb772 | |
| ToppCell | proximal-Hematologic-B_cell-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-05 | 197 | 39 | 4 | 08b3f2e3933242b9fa93998cfce3d094a3db833e | |
| ToppCell | proximal-3-Hematologic-B_cell|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.60e-05 | 197 | 39 | 4 | 81ba0eb2222e83b4ba2db3228dc04c390c2dbc63 | |
| ToppCell | mild-B_memory|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.71e-05 | 199 | 39 | 4 | 025bb65629d9e20c374e8f1ba08c36d1bb569190 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_hypoxia/MES-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.76e-05 | 200 | 39 | 4 | 851c57187db8bc91a393655bca5f13e787a723d4 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-6|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.95e-04 | 129 | 39 | 3 | 6071762027460b97c6642c58d06992f2b2703186 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.04e-04 | 131 | 39 | 3 | cc5b5afab8622e98f673fa116a226d930c295327 | |
| ToppCell | tumor_Lung-T/NK_cells-CD8_low_T|T/NK_cells / Location, Cell class and cell subclass | 2.59e-04 | 142 | 39 | 3 | eaf08a0dbacc9ebbd54e377922e76d8ba854dcb8 | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte-pericyte_D|E18.5-samps / Age Group, Lineage, Cell class and subclass | 2.98e-04 | 149 | 39 | 3 | dcf68eb25733b5db2893728fe4dca5c7267eb58c | |
| ToppCell | Healthy_donor-B_cell|World / disease group, cell group and cell class (v2) | 3.04e-04 | 150 | 39 | 3 | a2dfed562de7f58f902b547acec5a13853c80c4c | |
| ToppCell | 3'_v3-blood-Lymphocytic_T_CD4-Tfh|blood / Manually curated celltypes from each tissue | 3.28e-04 | 154 | 39 | 3 | 5ff380205fa7ab97ba21f6512bc9e14c0fb320b6 | |
| ToppCell | 367C-Lymphocytic-NK_cells-NK_cell_D2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.41e-04 | 156 | 39 | 3 | 0b3630fd4479291599e1674e87eba6f93877ac3a | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_B-Pro-B|bone_marrow / Manually curated celltypes from each tissue | 3.41e-04 | 156 | 39 | 3 | b093dbba6662e4fffc8aa577587b77f64ac44b56 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.47e-04 | 157 | 39 | 3 | 8c42af7aa1f1b6f4fe2f8d00a8b4a800f121e804 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.47e-04 | 157 | 39 | 3 | ee1be3c756b72fceac6b4ccb416dd4bd031a2193 | |
| ToppCell | PND28-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.47e-04 | 157 | 39 | 3 | 008f938a338f43c3251dcac574f1b4f689926c71 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.60e-04 | 159 | 39 | 3 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 3.60e-04 | 159 | 39 | 3 | d3202ddc291b8686dbe67690df13c7daffec2199 | |
| ToppCell | Control-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 3.60e-04 | 159 | 39 | 3 | 6f50c381cd8a26a5a90bf0ce909713cea96910d7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.67e-04 | 160 | 39 | 3 | e44b3c74c76b4632ada7f5bd6d09434b02d79743 | |
| ToppCell | droplet-Fat-Scat-21m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 161 | 39 | 3 | e52735f955f0a53da5cbe5a2d77a00484e5109b3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.74e-04 | 161 | 39 | 3 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 162 | 39 | 3 | ee6f05620f4f4ebbebd5b098afc7c20876e3d21f | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-04 | 162 | 39 | 3 | 9e72d468fcdd0d27b517a9e36efb35d4617a88f9 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-DZ_GC_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.81e-04 | 162 | 39 | 3 | 3e15b3e97a2ade86d0cb0ab15fccb9a2e2e27dd4 | |
| ToppCell | 3'_v3-GI_small-bowel-Lymphocytic_T_CD8-Tem/emra_CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.88e-04 | 163 | 39 | 3 | 1a8c79903ed416f286ebe8a9922233affbc55d82 | |
| ToppCell | LPS-antiTNF-Endothelial-Mes-Like-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-04 | 166 | 39 | 3 | 3b750d4023a0a09d86113aae5a97d84391f7b482 | |
| ToppCell | healthy_donor-Lymphocytic-Plasma_cell-IgM_Plasmablast|healthy_donor / Disease condition, Lineage, Cell class and subclass | 4.09e-04 | 166 | 39 | 3 | 2b7b580bec8d9467b0deaf97098065f72dbf2a4f | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-04 | 167 | 39 | 3 | c042d6cdddd0e1ddef1e3ac6f4fe23151127b0f2 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-04 | 167 | 39 | 3 | 7abc785e688a384672d7fb5a62d32538fe7e5a51 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-04 | 167 | 39 | 3 | d50311b1f66f143bae4c4cf50e2e9b13c85d6920 | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.16e-04 | 167 | 39 | 3 | 351f8de1fbdf742ac74f9099b254d515ab539bb2 | |
| ToppCell | TCGA-Thryoid-Primary_Tumor-Thyroid_Papillary_Carcinoma-Classical-8|TCGA-Thryoid / Sample_Type by Project: Shred V9 | 4.23e-04 | 168 | 39 | 3 | 00646601548b0fee42ae16bfa5e93603bc7c5129 | |
| ToppCell | Bronchial_Brush-Immune-B_cells|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 4.31e-04 | 169 | 39 | 3 | dc388f660f69e37e517bf3243daf071ab138ee6e | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-2|390C / Donor, Lineage, Cell class and subclass (all cells) | 4.31e-04 | 169 | 39 | 3 | cfc9ff103d13a2d5eacc457e800f53fdd29f7738 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.31e-04 | 169 | 39 | 3 | d721dbb317a88113b4f76688111908d00f23e899 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.31e-04 | 169 | 39 | 3 | 031465190cd3623a25ef2b868daab8d932c8ff08 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.38e-04 | 170 | 39 | 3 | e421f9eedf74baffda1d03707a710ece4b777f29 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-Memory_B_cells|Lung / Manually curated celltypes from each tissue | 4.46e-04 | 171 | 39 | 3 | 9ecef653f6916572bf5fbee5aea6c577d04e96ba | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.46e-04 | 171 | 39 | 3 | 15cb4670ff4234ac46aea8a5911138d6913c4482 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | b3c4adccc34bb9e4e78e40f4e2e23736c347cc75 | |
| ToppCell | P07-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.53e-04 | 172 | 39 | 3 | 9a256db817c1af1802203cc88a55d608fb328c63 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 172 | 39 | 3 | 08a3fe536b1b064c5ee7779bc2b1115a5963a26b | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil-Basophil_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 172 | 39 | 3 | c05af6e559f6af0fb15cefa03ffa1413e98a1a4a | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.53e-04 | 172 | 39 | 3 | 2f1673fcb2356684d60871debb0f159aec553a1c | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.53e-04 | 172 | 39 | 3 | 553701349444eb366df3c11f54bb093434f153c6 | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 4.53e-04 | 172 | 39 | 3 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Granulocytic-Basophil|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.53e-04 | 172 | 39 | 3 | 953b05f776348cff784e79c93df65841939d880f | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-04 | 173 | 39 | 3 | 3001dd39244ef0a5a475d569a78f4ae427a55db6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Degenerative_Vascular_Smooth_Muscle_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.61e-04 | 173 | 39 | 3 | c88883fb2a33e21d4201aa393674aa3f2ad780c9 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.61e-04 | 173 | 39 | 3 | 30d67738633493d47f06ae452424382f069b6c0a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 174 | 39 | 3 | 9c916af5eebd932f67dc9117e1d26ff194a2ff2c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.69e-04 | 174 | 39 | 3 | bc71521f44a5fe013af42b06b5d1bd2446ecf3b5 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.69e-04 | 174 | 39 | 3 | a9c6edf5c3fc119c24425f921c5566a8356c30fe | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | 1b35acece23712ab7e3f92d9d68266efd38b3ef5 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | 31f0fb2e47e357dbf9c15436b7df85b3c370ded7 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.77e-04 | 175 | 39 | 3 | 6a093c74a6f3daeff07759d6eec542fc5c709149 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 4.77e-04 | 175 | 39 | 3 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-basophil|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.77e-04 | 175 | 39 | 3 | a9f88054e2c28d604c65ed785f63021aadb7f4c8 | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell-endothelial_cell_of_lymphatic_vessel|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-04 | 175 | 39 | 3 | 84d252f3e432231687613299bbea14978bb4b06b | |
| ToppCell | P15-Endothelial-lymphatic_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.77e-04 | 175 | 39 | 3 | a00c6fa9b33640710dd05a3799031147196f0986 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte_proliferating-classical_monocyte_proliferating_l2|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.85e-04 | 176 | 39 | 3 | 1510cdfcfb46ce1196a1220c07fb5f3986c81b78 | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-04 | 176 | 39 | 3 | 8e7f38de8bf68077e2138f4d06c1f55b0fd096cc | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 176 | 39 | 3 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-Mesothelial-Mesothelial_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.85e-04 | 176 | 39 | 3 | ed575330a08a6748ea4b28433292c8cfd157d444 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.85e-04 | 176 | 39 | 3 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | LPS-IL1RA+antiTNF|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.93e-04 | 177 | 39 | 3 | b7fee75de7e96924af488a5baa2334711889ae7c | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Endothelial-lymphatic_endothelial-LEC2_(MADCAM1+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.93e-04 | 177 | 39 | 3 | 76f5df101c693e5fa61554244d877fc8169ee66f | |
| ToppCell | COVID-19_Moderate-B_intermediate|COVID-19_Moderate / disease group, cell group and cell class | 4.93e-04 | 177 | 39 | 3 | 68e3d12a0c048a2d0f1b9680c7338a35855bba30 | |
| ToppCell | droplet-Fat-SCAT-30m-Mesenchymal-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.01e-04 | 178 | 39 | 3 | 5cf12927f0756c4d8a289fe4308d736382e6212e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 178 | 39 | 3 | f815bc76f98aaea2d9058173b02b6f36e45283ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Lymphocytic_B-Plasma_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.01e-04 | 178 | 39 | 3 | a0334764e865fea652c54b94bbc3b173f7cbc9fc | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.01e-04 | 178 | 39 | 3 | 107dae8b00c4257697a63700e72bb434cdb8406f | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesothelial_cell_of_visceral_pleura|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.01e-04 | 178 | 39 | 3 | 1e05bc26591fea16e29bcfc5f538dda1dc427f05 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.09e-04 | 179 | 39 | 3 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | Control-Stromal-SMC|Control / Disease state, Lineage and Cell class | 5.09e-04 | 179 | 39 | 3 | 1378051bc62009eec2dbecf3d5d89baedbeb84eb | |
| ToppCell | COVID-19_Moderate-B_memory|World / disease group, cell group and cell class | 5.18e-04 | 180 | 39 | 3 | 2f37187b866edb56410c2334b72713f2248dc335 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | 3d95232b5785c705f41e01e3ffe0fa8dce1ff0a7 | |
| ToppCell | facs-Kidney-nan-24m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | f9f8245cbcdea18c15e2976c85b72c6807309787 | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell-B_activate-7|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-04 | 180 | 39 | 3 | 9f4bbaf6435c23e3e552ae22be8ea7884314192d | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-04 | 180 | 39 | 3 | b465f2f8b0e9a2034a4f1272bb00c77439164dbf | |
| ToppCell | P28-Mesenchymal-mesenchymal_fibroblast-mesenchymal_alveolar_niche_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 5.18e-04 | 180 | 39 | 3 | 9adebde5f4ca6dcb90e9113622862e14298465ac | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-Cycling_plasma_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.18e-04 | 180 | 39 | 3 | ce2fc270f9d9110c2544083f61936b0b7d3b7eb3 | |
| ToppCell | droplet-Liver-LIVER-30m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.18e-04 | 180 | 39 | 3 | 47e345359064dc8ceec982b062e47802e728b43f | |
| ToppCell | BAL-Severe-Lymphocyte-B-B_cell|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.18e-04 | 180 | 39 | 3 | c3c72531af5b9f7a7416727fe609dab5180e03b6 | |
| Disease | chronic granulomatous disease (implicated_via_orthology) | 1.81e-08 | 5 | 37 | 3 | DOID:3265 (implicated_via_orthology) | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 3.96e-07 | 12 | 37 | 3 | DOID:7148 (implicated_via_orthology) | |
| Disease | Clear-cell metastatic renal cell carcinoma | 9.17e-06 | 4 | 37 | 2 | C2931852 | |
| Disease | Carcinoma, Pancreatic Ductal | 4.15e-04 | 24 | 37 | 2 | C0887833 | |
| Disease | serum gamma-glutamyl transferase measurement | 8.89e-04 | 914 | 37 | 6 | EFO_0004532 | |
| Disease | Huntington's disease (is_marker_for) | 2.03e-03 | 53 | 37 | 2 | DOID:12858 (is_marker_for) | |
| Disease | systemic scleroderma (is_marker_for) | 2.03e-03 | 53 | 37 | 2 | DOID:418 (is_marker_for) | |
| Disease | hair morphology measurement | 2.10e-03 | 54 | 37 | 2 | EFO_0007821 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVFRSRRAQRQRQQR | 566 | P21709 | |
| VVHRLRQAQRRPQRQ | 241 | P32302 | |
| RQAQRRPQRQKAVRV | 246 | P32302 | |
| TLGQRRAQARRQTIR | 591 | P26358 | |
| MTPQQRRLQQRRLQH | 1011 | Q8IUX7 | |
| QRHTQRDPRQARQQQ | 41 | A1A5B4 | |
| GQINRQTQRQRRVRR | 141 | Q9Y2E6 | |
| RQAQHRYQQQQRRRR | 891 | Q9HCE9 | |
| QGRPRQASRSRQNQR | 156 | O60258 | |
| QRNRGNRLQDNRQFR | 51 | Q9BTL3 | |
| VRPANQRNNVVRNSR | 246 | Q9BYG5 | |
| RLRRPQQQQERAQRP | 196 | Q96PE2 | |
| RGRQQREQEQRRLSQ | 171 | Q6NSJ2 | |
| QVNDENRRPQRRRSG | 211 | Q9BX40 | |
| NRRTRNRSRGQNRPT | 226 | Q9BX40 | |
| RNSVRFLQQRRRQAR | 326 | P14598 | |
| QELNNSRPARQVRRL | 31 | Q9NWM3 | |
| NRRNNRNKRNRQNRS | 641 | Q1KMD3 | |
| ALQRQLEQRQSRRRN | 41 | Q9NUL7 | |
| RRNSVRFLQQRRRQA | 326 | A6NI72 | |
| RRNSVRFLQQRRRQA | 301 | A8MVU1 | |
| PSKARQRQRQRQRAA | 776 | Q9P2Q2 | |
| LLQLSRRVRRNRNVN | 111 | P08311 | |
| QQSRRQRIIQRNRTE | 576 | P13807 | |
| TARPQDVNRRDQQRN | 126 | P24592 | |
| QRRQVQRSQRRAPHL | 386 | Q7Z6J9 | |
| SNSRGVQLFNRRRQR | 166 | Q8N3V7 | |
| RFLRNSRVRRQAQQV | 991 | Q8N122 | |
| VQGRVPSRRQQRASR | 1146 | O75339 | |
| LRPSRDSQQRVRRNL | 76 | Q96CW6 | |
| RFQRRRRQLQQQQPR | 6 | Q5VWI1 | |
| RRQLQQQQPRRRQPL | 11 | Q5VWI1 | |
| RGRSRRLQQRQQLAE | 146 | Q6XR72 | |
| QRVQERQRRLGQSRA | 261 | Q86UD0 | |
| DRQRNTASLRNPFQR | 1686 | Q9HCF6 | |
| RQPLNRNSLRRQNLT | 201 | Q96A56 | |
| QRSLRRRQQQDLMPQ | 471 | P35916 | |
| SPRQRRAQQQSQRRL | 251 | Q9Y385 | |
| PQQARSLLQRVRRAN | 31 | P00734 | |
| NQVVPNRTTLQGRRR | 426 | Q5T5U3 | |
| RNPQQRRISQSQPVR | 1541 | O95071 | |
| RAQLSVKNRRQRPSR | 886 | Q9ULJ8 |